You have 9 free searches left this month | to do more

TG-1701

TG 1701 is a drug used to treat Chronic Lymphocytic Leukemia and Non Hodgkin Lymphoma. TG 1701 is being actively studied in 1 study; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
TG Therapeutics, Inc.TG Therapeutics Investigational Trial Site
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • TG-1701
  • +2 more
  • East Melbourne, Victoria, Australia
  • +7 more
2022-01-12
Jan 12, 2022